Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology
Published: Mar 14, 2013
REDWOOD CITY, CALIF, March 14, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced their receipt of the 2013 Drug Delivery Partnerships™ (DDP) Innovation Award for the Company's novel co-suspension formulation technology. These awards honor companies that have demonstrated exemplary leadership and scientific/technological innovation in the field of drug delivery and development. The award to Pearl was announced at the 4th annual Drug Delivery Partnership conference held by Institute for International Research.